| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/04/2007 | WO2006060765A3 Use of a compound that activates a vitamin d receptor for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals |
| 01/04/2007 | WO2006041872A3 Thrombin receptor antagonists |
| 01/04/2007 | WO2005123050A3 Five-membered heterocycles useful as serine protease inhibitors |
| 01/04/2007 | WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/04/2007 | US20070004746 Imatinib mesylate; antitumor agent |
| 01/04/2007 | US20070004740 phosphodiesterase 4 inhibitors which are naphthalene compounds such as 6,7-Dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene; asthma or inflammatory diseases |
| 01/04/2007 | US20070004739 Condensed polycyclic compounds |
| 01/04/2007 | US20070004736 Imidazole derivative, process for producing the same, and use |
| 01/04/2007 | US20070004716 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070004668 Antisense permeation enhancers |
| 01/04/2007 | US20070003630 Anti-angiogenic compositions and methods of use |
| 01/04/2007 | US20070003629 Anticancer agents; prevent forming blood vessels; removal blockage |
| 01/04/2007 | US20070003556 Modified antibodies against cd22 and utilization thereof |
| 01/04/2007 | US20070003553 Anticoagulant agents useful in treatment of thrombosis |
| 01/04/2007 | US20070003551 Immunoglobulin |
| 01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
| 01/03/2007 | EP1739093A1 Separation of plasma proteins |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1738754A1 Solid pharmaceutical preparation |
| 01/03/2007 | EP1737816A1 Integrin modulators and methods for their use |
| 01/03/2007 | EP1737484A1 Combination dosing regimen for erythropoietin |
| 01/03/2007 | EP1436389B1 Thrombin-cleavable chimeric proteins |
| 01/03/2007 | EP1347780B1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 01/03/2007 | EP1223944B1 Thrombopoietin mimetics |
| 01/03/2007 | EP1221439B1 Tetrahydroquinoline derivatives |
| 01/03/2007 | EP1126839B1 Substituted phenethylsulfones and method of reducing tnf-alpha and pde-iv levels |
| 01/03/2007 | EP0942996B1 Thrombolytic agents with antithrombotic activity |
| 01/03/2007 | EP0863768B1 Covalent heparin-protein conjugates comprising an alpha-carbonyl amine bond and methods of obtaining them |
| 01/03/2007 | CN1890369A Bispecific antibody substituting for functional proteins |
| 01/03/2007 | CN1890262A Method of producing antithrombin iii composition |
| 01/03/2007 | CN1890214A Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 01/03/2007 | CN1887943A Filming gel composition and its use |
| 01/03/2007 | CN1887347A Prepn technology of antithrombotic hirudin aerosol |
| 01/03/2007 | CN1887284A Medicine composition of trifusal and clopidogrel |
| 01/03/2007 | CN1887283A Medicine composition containing bailobalide |
| 01/03/2007 | CN1887282A Medicine composition containing bailobalide |
| 01/03/2007 | CN1293193C Gene clone of and expression Japan lamprey oral cavity gland KGD model protein possessing anti thrombotic action |
| 01/03/2007 | CN1293074C Arylindenopyridines with PDE inhibiting activity |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293055C Piperidine derivative crystal, midbody for preparation and preparing method |
| 01/03/2007 | CN1292790C Chinese traditional medicine for preventing and curing cardiovascular and cerebrovascular diseases |
| 01/03/2007 | CN1292755C Application of CMC grafted polyacrylic acid in preparing hemostatic and hemostatic material |
| 01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
| 01/02/2007 | US7157456 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157445 Administration of enoxaparin sodium to patients with severe renal impairment |
| 01/02/2007 | US7157436 An specific oligonucleotide sequence conataining 2-20 base 3'OH, 5'OH synthetic oligonucleotide which induces a response selected from cell cycle arrest, inhibition of cell proliferation, activation of caspases in cancer cells |
| 01/02/2007 | US7157241 Dipeptidyl peptidase IV (DPPIV); given sequences; homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | US7157101 Micronized eplerenone compositions |
| 01/02/2007 | US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation. |
| 01/02/2007 | CA2373999C Pyrazinone thrombin inhibitors |
| 01/02/2007 | CA2295219C Integrin binding peptide and use thereof |
| 01/02/2007 | CA2235996C New compounds and their compositions having anti-inflammatory and anti-thrombotic activities |
| 01/02/2007 | CA2208129C Process for the preparation of chiral, nonracemic (4-aryl-2, 5-dioxoimidazo-lidin-1-yl)acetic acids |
| 01/02/2007 | CA2174517C Receptor specific atrial natriuretic peptides |
| 12/29/2006 | CA2551345A1 Process for separating fibrinogen proteins, factor xiii and biological glue from a soluble plasma fraction and for preparing lyophilized concentrates of the said proteins |
| 12/28/2006 | WO2006138534A2 Stable warfarin sodium liquid formulation and method of making same |
| 12/28/2006 | WO2006137772A1 New physical form of n,n´- disubstituted oxabispidines |
| 12/28/2006 | WO2006137510A1 Agent for reduction of bleeding in cerebrovascular disorder |
| 12/28/2006 | WO2006137466A1 Pharmaceutical composition |
| 12/28/2006 | WO2006137395A1 Amide derivative, pesticide containing such compound and use thereof |
| 12/28/2006 | WO2006136033A1 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 12/28/2006 | WO2006135973A1 Small molecule glycosaminoglycan mimetics |
| 12/28/2006 | WO2006108670A3 Use of cd25 antibodies in immunotherapy |
| 12/28/2006 | WO2006094292A3 Thienopyridine compounds, and methods of use thereof |
| 12/28/2006 | WO2006089954A3 Compounds for stabilizing factor vii polypeptide formulations |
| 12/28/2006 | WO2006041409A8 Medical solution, method for producing and use thereof |
| 12/28/2006 | US20060293338 protein serine/threonine kinase inhibitors such as 2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one, used for treating autoimmune diseases, HIV, cancer, anemia myelodysplastic syndrome and thrombocytopenia |
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | US20060293275 Hgf production accelerator containing heparin-like oligosaccharide |
| 12/28/2006 | US20060293252 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 12/28/2006 | US20060292622 determining the presence of or predisposition to early-onset spinocerebellar ataxia with ocular motor aprataxia and hypoalbuminemia in a human; neurodegenerative disease |
| 12/28/2006 | US20060292242 Use of zeolithes for reducing the proportion of lactates and ammonium in human and animal organisms |
| 12/28/2006 | US20060292149 antihemophilic factor monoclonal antibodies comprising an immunoglobulin heavy chain and light chain amino acid sequences, with modified by enzymatic deglycosylation or by site directed mutagenesis, used for treating hemostasis disorders; anticoagulants |
| 12/28/2006 | US20060292131 Chondrocyte Therapeutic Delivery System |
| 12/28/2006 | US20060292075 Labelled glutamine and lysine analogues |
| 12/28/2006 | CA2612859A1 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 12/28/2006 | CA2612507A1 Amide derivative, insecticide containing the same and method for application thereof as insecticide |
| 12/28/2006 | CA2598216A1 Androgen receptor modulator compounds and methods |
| 12/27/2006 | EP1736775A1 Novel ligand of g protein coupled receptor protein and use thereof |
| 12/27/2006 | EP1736541A1 Novel galectin 9 modification protein and use thereof |
| 12/27/2006 | EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators |
| 12/27/2006 | EP1736469A2 Processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-Fluorophenyl)ethyl]-4-piperidinemethanol |
| 12/27/2006 | EP1736148A1 Medical emulsion of perfluororganic compounds and method for the production thereof |
| 12/27/2006 | EP1735296A1 Materials and methods for treating coagulation disorders |
| 12/27/2006 | EP1735279A1 Prolinyl derivates for treating thrombosis |
| 12/27/2006 | EP1734983A2 Modified annexin proteins and methods for preventing thrombosis |
| 12/27/2006 | EP1734941A2 Neural tourniquet |
| 12/27/2006 | EP1734821A2 Activators of hexosamine biosynthesis as inhibitors of injury induced by ischemia or hemorrhagic shock |
| 12/27/2006 | EP1443925B1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 12/27/2006 | EP1427423B1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 12/27/2006 | EP1353928B1 Process for preparing clopidogrel |
| 12/27/2006 | EP1299374B1 Novel non-psychotropic cannabinoids |
| 12/27/2006 | EP1284717B1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 12/27/2006 | EP1117437B1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 12/27/2006 | CN1886423A Glycoisoforms of adiponectin and uses thereof |
| 12/27/2006 | CN1886375A Piperidine compound and method for producing same |